(Q48172859)

9 February 2018

title

Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase (English)

1 reference

9 February 2018

1 reference

1 reference

Benjamin G Clissold

3

0 references

Jane E. Alty

object named as

Jane E Alty

2

0 references

author name string

Ganesvaran Ganga

1

1 reference

9 February 2018

Craig D McColl

4

1 reference

9 February 2018

Katrina A Reardon

5

1 reference

9 February 2018

Mark Schiff

6

1 reference

9 February 2018

Peter A Kempster

7

1 reference

9 February 2018

language of work or name

English

0 references

publication date

6 February 2013

1 reference

9 February 2018

published in

Movement Disorders

1 reference

9 February 2018

volume

28

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

476-481

1 reference

9 February 2018

Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinson disease.

cites work

1 reference

The long-duration response to L-dopa in the treatment of early PD.

21 January 2018

1 reference

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

21 January 2018

1 reference

21 January 2018

1 reference

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists

21 January 2018

1 reference

Rate of clinical progression in Parkinson's disease. A prospective study.

21 January 2018

1 reference

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.

21 January 2018

1 reference

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group

21 January 2018

1 reference

A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

21 January 2018

1 reference

Clinical heterogeneity in newly diagnosed Parkinson's disease.

21 January 2018

1 reference

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

21 January 2018

1 reference

The association between motor subtypes and psychopathology in Parkinson's disease

21 January 2018

1 reference

Changes in motor subtype and risk for incident dementia in Parkinson's disease

21 January 2018

1 reference

The natural history of treated Parkinson's disease in an incident, community based cohort

21 January 2018

1 reference

Functional decline in Parkinson disease

21 January 2018

1 reference

Progression of parkinsonian signs in Parkinson disease.

21 January 2018

1 reference

Progression of motor impairment and disability in Parkinson disease: a population-based study.

21 January 2018

1 reference

Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease.

21 January 2018

1 reference

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25335

1 reference

9 February 2018

1 reference

9 February 2018